X hits on this document

Word document

The usefulness and use of second-generation - page 54 / 81





54 / 81

178 Wetzel H, von Bardeleben U, Holsboer F, Benkert O. Zotepine versus perazine in patients with paranoid schizophrenia: a double-blind controlled trial of its effectiveness. Fortschr Neurol Psychiatr 1991; 59 (Suppl 1):23-29.

179 Fleischhacker WW, Barnas C, Stuppack CH, et al. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial. Psychopharmacol Bull 1989; 25:97-100.

180 Fleischhacker WW, Barnas C, Stuppack C, et al. Zotepine in the treatment of negative symptoms in chronic schizophrenia. Pharmacopsychiatry 1987; 20:58-60.

181 Sarai K, Okada M. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study. Pharmacopsychiatry 1987; 20:38-46.

182 Taylor, D and Aitchison, K. The pharmaco-economics of atypical antipsychotics. Int J Psychiatry  Clin Pract 1999; 3:237-248.  

183 Taylor D. Schizophrenia. In: Taylor D, Knapp M, Kerwin R, editors. Pharmacoeconomics in Psychiatry. London: Martin Dunitz; 2002. pp. 19-42.

184 Tarricone R, Gerzeli S, Montanelli R, et al. Direct and indirect costs of schizophrenia in community psychiatric services in Italy. The GISIES study. Interdisciplinary Study Group on the Economic Impact of Schizophrenia. Health Policy 2000; 51:1-18.

185Knapp M, Chisholm D, Leese M, et al. Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. Acta Psychiatr Scand 2002; 105:42-54.

186 Knapp M, Mangalore R, Simon J.  The global costs of schizophrenia.  2002b.

187 Essock SM, Frisman LK, Covell NH, Hargreaves WA. Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals. Arch Gen Psychiatry 2000; 57:987-994.

188. Sernyak MJ, Rosenheck R, Desai R, et al. Impact of clozapine prescription on inpatient resource utilization. J Nerv Ment Dis 2001; 189:766-773.

189 Rabinowitz J, Lichtenberg P, Kaplan Z, et al. Rehospitalization rates of chronically ill schizophrenic patients discharged on a regimen of risperidone, olanzapine, or conventional antipsychotics. Am J

Document info
Document views325
Page views325
Page last viewedMon Jan 23 13:05:23 UTC 2017